Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Galectin 3 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Galectin 3market, defines the market attractiveness level of Galectin 3 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Galectin 3 industry, describes the types of Galectin 3 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Galectin 3 market and the development prospects and opportunities of Galectin 3 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Galectin 3 market in Chapter 13.
By Player:
iTeos Therapeutics SA
Galectin Therapeutics Inc
Angion Biomedica Corp
GlycoMimetics Inc
Bristol-Myers Squibb Company
MandalMed Inc
By Type:
GAL-300
GRMD-03
ANG-4021
KTI
Others
By End-User:
Liver Cirrhosis
Portal Hypertension
Metastatic Melanoma
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Galectin 3 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Galectin 3 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Galectin 3 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Galectin 3 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Galectin 3 Market Analysis and Outlook to 2022
-
7.1 Global Galectin 3 Consumption (2017-2022)
-
7.2 United States Galectin 3 Consumption (2017-2022)
-
7.3 Europe Galectin 3 Consumption (2017-2022)
-
7.4 China Galectin 3 Consumption (2017-2022)
-
7.5 Japan Galectin 3 Consumption (2017-2022)
-
7.6 India Galectin 3 Consumption (2017-2022)
-
7.7 South Korea Galectin 3 Consumption (2017-2022)
8 Region and Country-wise Galectin 3 Market Analysis and Outlook to 2028
-
8.1 Global Galectin 3 Consumption Forecast (2022-2028)
-
8.2 United States Galectin 3 Consumption Forecast (2022-2028)
-
8.3 Europe Galectin 3 Consumption Forecast (2022-2028)
-
8.4 China Galectin 3 Consumption Forecast (2022-2028)
-
8.5 Japan Galectin 3 Consumption Forecast (2022-2028)
-
8.6 India Galectin 3 Consumption Forecast (2022-2028)
-
8.7 South Korea Galectin 3 Consumption Forecast (2022-2028)
9 Global Galectin 3 Market Outlook by Types and Applications to 2022
-
9.1 Global Galectin 3 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GAL-300 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global GRMD-03 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ANG-4021 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global KTI Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Galectin 3 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Liver Cirrhosis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Portal Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Metastatic Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Galectin 3 Market Outlook by Types and Applications to 2028
-
10.1 Global Galectin 3 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global GAL-300 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global GRMD-03 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global ANG-4021 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global KTI Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Galectin 3 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Liver Cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Portal Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Metastatic Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Galectin 3 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Galectin 3 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Galectin 3 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Galectin 3 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Galectin 3 Market Competitive Analysis
-
14.1 iTeos Therapeutics SA
-
14.1.1 iTeos Therapeutics SA Company Details
-
14.1.2 iTeos Therapeutics SA Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 iTeos Therapeutics SA Galectin 3 Product and Service
-
14.2 Galectin Therapeutics Inc
-
14.2.1 Galectin Therapeutics Inc Company Details
-
14.2.2 Galectin Therapeutics Inc Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Galectin Therapeutics Inc Galectin 3 Product and Service
-
14.3 Angion Biomedica Corp
-
14.3.1 Angion Biomedica Corp Company Details
-
14.3.2 Angion Biomedica Corp Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Angion Biomedica Corp Galectin 3 Product and Service
-
14.4 GlycoMimetics Inc
-
14.4.1 GlycoMimetics Inc Company Details
-
14.4.2 GlycoMimetics Inc Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlycoMimetics Inc Galectin 3 Product and Service
-
14.5 Bristol-Myers Squibb Company
-
14.5.1 Bristol-Myers Squibb Company Company Details
-
14.5.2 Bristol-Myers Squibb Company Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Company Galectin 3 Product and Service
-
14.6 MandalMed Inc
-
14.6.1 MandalMed Inc Company Details
-
14.6.2 MandalMed Inc Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 MandalMed Inc Galectin 3 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Galectin 3
-
Figure Galectin 3 Picture
-
Table Global Galectin 3 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Galectin 3 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Galectin 3 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Galectin 3 Consumption by Country (2017-2022)
-
Figure United States Galectin 3 Consumption and Growth Rate (2017-2022)
-
Table Europe Galectin 3 Consumption and Growth Rate (2017-2022)
-
Figure China Galectin 3 Consumption and Growth Rate (2017-2022)
-
Figure Japan Galectin 3 Consumption and Growth Rate (2017-2022)
-
Figure India Galectin 3 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Galectin 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Galectin 3 Consumption Forecast by Country (2022-2028)
-
Figure United States Galectin 3 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Galectin 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Galectin 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Galectin 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Galectin 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Galectin 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GAL-300 Consumption and Growth Rate (2017-2022)
-
Figure Global GRMD-03 Consumption and Growth Rate (2017-2022)
-
Figure Global ANG-4021 Consumption and Growth Rate (2017-2022)
-
Figure Global KTI Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cirrhosis Consumption and Growth Rate (2017-2022)
-
Figure Global Portal Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global GAL-300 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GRMD-03 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ANG-4021 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global KTI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Portal Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metastatic Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Galectin 3 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Galectin 3 Export by Region (Top 5 Countries) (2017-2028)
-
Table iTeos Therapeutics SA (Foundation Year, Company Profile and etc.)
-
Table iTeos Therapeutics SA Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
Table iTeos Therapeutics SA Galectin 3 Product and Service
-
Table Galectin Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Galectin Therapeutics Inc Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galectin Therapeutics Inc Galectin 3 Product and Service
-
Table Angion Biomedica Corp (Foundation Year, Company Profile and etc.)
-
Table Angion Biomedica Corp Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Angion Biomedica Corp Galectin 3 Product and Service
-
Table GlycoMimetics Inc (Foundation Year, Company Profile and etc.)
-
Table GlycoMimetics Inc Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlycoMimetics Inc Galectin 3 Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Galectin 3 Product and Service
-
Table MandalMed Inc (Foundation Year, Company Profile and etc.)
-
Table MandalMed Inc Galectin 3 Sales, Price, Value and Gross Profit (2017-2022)
-
Table MandalMed Inc Galectin 3 Product and Service
-
